Results 141 to 150 of about 18,145 (196)

Anti-vascular endothelial growth factors in retinal and choroidal diseases - Present landscape. [PDF]

Indian J Ophthalmol
Kannan NB, Vallinayagam M, Rishitha K, Ramasamy K.   +3 more
europepmc   +1 more source

Biosimilar anti-vascular endothelial growth factor agents: Clinical outcomes, safety, and cost-effectiveness in India. [PDF]

Indian J Ophthalmol
Chakraborty D, Sinha TK, Boral S, Das A.
europepmc   +1 more source

Paradoxical angiogenic activation under anti-VEGF therapy: tip cell hyper-sprouting and vessel remodeling drive inefficient vascularization in multiscale tumor simulations. [PDF]

BMC Cancer
Manshadi MD, Soltani M.
europepmc   +1 more source

Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life. [PDF]

PLoS One
Chowdhury JM.
europepmc   +1 more source

Real-World Comparison of Biosimilar Ranibizumab (Ranieyes) and Innovator Ranibizumab (Lucentis/Accentrix) Across Multiple Retinal Vascular Diseases (The BRIO Study). [PDF]

Pharmaceuticals (Basel)
Chakraborty D, Sinha TK, Sinha S, Biswas RK, Das A, Maiti A, Bhattacharya R, Dan S, Rungta D, Das S.   +9 more
europepmc   +1 more source

Reactivation of Choroidal Neovascularization in Bilateral Punctate Inner Choroidopathy: A Case Report. [PDF]

Cureus
Zainuddin NS, Bahari N, Mohd Khialdin S.
europepmc   +1 more source

Infants with retinopathy of prematurity (ROP) in Germany and Türkiye-a comparison based on data from the EU-ROP registry. [PDF]

Front Med (Lausanne)
Pfeil JM, Schnorr SC, Meinheit E, Özdek Ş, Uzun A, Kara C, Barth T, Yucel OE, Gabel-Pfisterer A, Schöneberger V, Kadayifcilar S, Bleul T, Breuss H, Atilla H, Krohne TU, Hufendiek K, Eter N, Aisenbrey S, Skevas C, Süsskind D, Schulze K, Işık P, Jendritza W, Gniesmer S, Saßmannshausen M, Spital G, Kakkassery V, Aljarmakani T, Akkoyun I, Bartmann IR, Baumgarten S, Finger RP, Parlak M, Chankiewitz E, Stahl A, EU-ROP Study Group, EU-ROP Study Group .   +36 more
europepmc   +1 more source

Anti-VEGF therapy for posterior segment disorders: The story so far…. [PDF]

Indian J Ophthalmol
Chawla R.
europepmc   +1 more source

From bench to bed: The evolution of anti-vascular endothelial growth factor therapies. [PDF]

Indian J Ophthalmol
Sen A, Kohli G, Agarwal A, Chauhan R.
europepmc   +1 more source

Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization. [PDF]

Medicine (Baltimore)
Kung YH, Peng KL, Shih LY, Wu TT.
europepmc   +1 more source